1. Home
  2. OFIX vs GOSS Comparison

OFIX vs GOSS Comparison

Compare OFIX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

N/A

Current Price

$12.54

Market Cap

534.6M

Sector

Health Care

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$0.56

Market Cap

615.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFIX
GOSS
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
534.6M
615.7M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
OFIX
GOSS
Price
$12.54
$0.56
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$18.25
$4.91
AVG Volume (30 Days)
279.6K
27.3M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.39
78.81
EPS
N/A
N/A
Revenue
$822,312,000.00
$114,701,000.00
Revenue This Year
$6.32
N/A
Revenue Next Year
$6.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$10.25
$0.33
52 Week High
$17.28
$3.87

Technical Indicators

Market Signals
Indicator
OFIX
GOSS
Relative Strength Index (RSI) 35.47 24.60
Support Level $12.33 $0.33
Resistance Level $16.13 $1.23
Average True Range (ATR) 0.60 0.10
MACD -0.05 -0.02
Stochastic Oscillator 19.35 12.16

Price Performance

Historical Comparison
OFIX
GOSS

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: